Drug Trial Radar · NCT06039449
A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2
Last checked: Nov 19, 2026Latest source record: Dec 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
790
Actual
Start
Sep 8, 2023
Primary completion
Nov 19, 2024
Study completion Nov 19, 2024
Sponsor
- Lead sponsor
- Invivyd, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 15, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A study to investigate the prevention of COVID-19 with VYD222 in adults with immune compromise and in participants aged 12 years or older who are at risk of exposure to SARS-CoV-2
Conditions
- COVID-19
- SARS-CoV-2
Interventions
VYD222 (pemivibart)Drug
Participants will be dosed on Day 1 followed by redosing at Month 3 (approximately 90 days) with VYD222.
Normal salineDrug
Participants will be dosed on Day 1 followed by redosing at Month 3 (approximately 90 days) with Placebo.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cohort A - Incidence of treatment emergent adverse eventsTime frame: Through Month 12
- Cohort A - Ratio of SARS-CoV-2 sVNA titer against a relevant variant following VYD222 administration at Day 28 compared to a prespecified SARS-CoV-2 sVNA titer threshold.Time frame: Day 28
- Cohort B - Incidence of treatment emergent adverse eventsTime frame: Through Month 12
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
INVIVYD Investigative Site
Fullerton, California
INVIVYD Investigative Site
Long Beach, California
INVIVYD Investigative Site
Rolling Hills Estates, California
INVIVYD Investigative Site
San Diego, California
INVIVYD Investigative Site
Clearwater, Florida
INVIVYD Investigative Site
Miami, Florida
INVIVYD Investigative Site
St. Petersburg, Florida
INVIVYD Investigative Site
Atlanta, Georgia
INVIVYD Investigative Site
Hinesville, Georgia
INVIVYD Investigative Site
Oak Brook, Illinois
INVIVYD Investigative Site
Silver Spring, Maryland
INVIVYD Investigative Site
Burlington, Massachusetts
INVIVYD Investigative Site
Morrisville, North Carolina
INVIVYD Investigative Site
Salisbury, North Carolina
INVIVYD Investigative Site
Edmond, Oklahoma
INVIVYD Investigative Site
Yukon, Oklahoma
INVIVYD Investigative Site
Beaumont, Texas
INVIVYD Investigative Site
Dallas, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.